- Home
- YSXT vs MNOV Comparison
YSXT vs MNOV Comparison
Compare YSXT & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSXT
- MNOV
- Stock Information
- Founded
- YSXT 2011
- MNOV 2000
- Country
- YSXT China
- MNOV United States
- Employees
- YSXT N/A
- MNOV N/A
- Industry
- YSXT Automotive Aftermarket
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- YSXT Consumer Discretionary
- MNOV Health Care
- Exchange
- YSXT Nasdaq
- MNOV Nasdaq
- Market Cap
- YSXT 127.7M
- MNOV 68.2M
- IPO Year
- YSXT 2024
- MNOV 2005
- Fundamental
- Price
- YSXT $5.29
- MNOV $1.32
- Analyst Decision
- YSXT
- MNOV Strong Buy
- Analyst Count
- YSXT 0
- MNOV 2
- Target Price
- YSXT N/A
- MNOV $7.00
- AVG Volume (30 Days)
- YSXT 280.8K
- MNOV 13.0K
- Earning Date
- YSXT 08-15-2025
- MNOV 08-07-2025
- Dividend Yield
- YSXT N/A
- MNOV N/A
- EPS Growth
- YSXT N/A
- MNOV N/A
- EPS
- YSXT 0.18
- MNOV N/A
- Revenue
- YSXT $66,143,276.00
- MNOV N/A
- Revenue This Year
- YSXT N/A
- MNOV N/A
- Revenue Next Year
- YSXT N/A
- MNOV N/A
- P/E Ratio
- YSXT $30.03
- MNOV N/A
- Revenue Growth
- YSXT 21.23
- MNOV N/A
- 52 Week Low
- YSXT $2.06
- MNOV $1.12
- 52 Week High
- YSXT $9.96
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- YSXT N/A
- MNOV 45.64
- Support Level
- YSXT N/A
- MNOV $1.32
- Resistance Level
- YSXT N/A
- MNOV $1.38
- Average True Range (ATR)
- YSXT 0.00
- MNOV 0.05
- MACD
- YSXT 0.00
- MNOV 0.00
- Stochastic Oscillator
- YSXT 0.00
- MNOV 44.44
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.